“The future is already here – it’s just not very evenly distributed.” – William Gibson
This is a blog about next-generation sequencing and it’s intersection with marketing and business in general (primarily), which happens to be my particular area of professional expertise, having focused on next-generation sequencing since late 2006, when Illumina (my then-employer) acquired a startup called Solexa for $417M. I have had product development, product management, marketing (all in the San Diego area with Illumina) and key-account sales roles (in the Mid-Atlantic region of the US serving both the NIH and the entire SouthEast region with Illumina, RainDance Technologies and currently with Life Technologies). I am presently in a marketing role at Life Technologies Corporation (which used to be Applied Biosystems and Invitrogen Corporation), heavily involved with both the Ion Torrent PGM / Proton as well as the SOLiD / 5500 platforms. (More information about me can be found here; if you are interested in anything Ion Torrent and NGS market overall you’ve come to the right place.)